Company Number: 13896320

Analysis Date: 2025-07-20 14:28 UTC

Comprehensive Financial Health Assessment of Clinical Comms Group Ltd

---

1. Financial Health Score: D

Explanation:
The company shows several "symptoms of financial distress," such as persistent negative working capital and minimal net asset base. Despite being operational and filing on time, the financial "vital signs" reveal a fragile liquidity position and very thin equity, which suggests vulnerability to financial shocks. The score D reflects a need for urgent "treatment" to improve balance sheet strength and cash flow.

---

2. Key Vital Signs

Metric	Value (2024)	Interpretation
Fixed Assets	£1,630	Very low investment in long-term assets; typical for a micro entity in an early stage.
Current Assets	£82,230	Liquid assets including cash and receivables; reduced by over 50% compared to prior year.
Current Liabilities	£83,480	Obligations due within one year; slightly higher than current assets, causing negative working capital.
Net Current Assets (Working Capital)	-£1,250	Negative working capital indicates short-term liquidity strain; a "symptom of distress."
Total Assets Less Current Liabilities	£380	Very thin net asset base reflecting minimal equity cushion.
Shareholders’ Funds (Equity)	£380	Indicates the company is barely above break-even in net worth; limited financial buffer.
Directors’ Advances	£30,427 (each of two directors)	Significant reliance on director loans to support operations, a sign of external funding dependency.

---

3. Diagnosis

Clinical Comms Group Ltd is a micro-entity operating in specialized medical practice and management consultancy. The company is young, incorporated in 2022, and has a small workforce (3 employees). The financial "vital signs" reveal persistent negative net current assets over the last two years, indicating ongoing short-term liquidity challenges. The company’s total net assets are minimal and have only slightly increased from £211 to £380.

The significant director loans (£30,427 each) highlight that the business depends heavily on internal financing to maintain operations, which is a typical "band-aid" for cash flow issues but not sustainable long-term without improving profitability or securing external funding. The reduction in current assets by over 50% from the prior year signals a potential decrease in cash or receivables, increasing liquidity risk.

There are no signs of overdue filings or legal distress, which is positive. However, the financial structure is fragile, with limited buffer to absorb shocks or invest in growth. The company is not audited but files under micro-entity provisions, which limits the detail available but is typical for its size.

---

4. Recommendations

• Improve Cash Flow Management:
  Conduct a detailed cash flow forecast to identify timing gaps. Accelerate receivables collection and negotiate better payment terms with suppliers to reduce negative working capital.

• Strengthen Equity Base:
  Consider additional equity injections from shareholders or external investors to increase shareholders’ funds and create a financial cushion.

• Reduce Dependency on Director Loans:
  While director advances provide immediate relief, formalizing repayment plans or converting loans into equity could stabilize the balance sheet.

• Cost Control and Revenue Enhancement:
  Analyze operating expenses to identify cost-saving opportunities. Explore growth strategies in the medical and consultancy sectors to increase revenues sustainably.

• Regular Financial Monitoring:
  Implement monthly financial reviews with key ratios (liquidity, solvency) to detect early signs of trouble and adjust strategies promptly.

• Prepare for Growth:
  As the company is in a niche sector, investing modestly in fixed assets and technology may improve service delivery and competitive positioning, but only after stabilizing liquidity.

---

Medical Analogy Summary

Clinical Comms Group Ltd currently exhibits "symptoms" of financial strain—negative working capital and minimal equity—akin to a patient with low blood pressure and weak pulse. The reliance on director loans is equivalent to emergency support, not a cure. Without intervention to boost cash flow and strengthen the balance sheet, the company risks financial "collapse." Prompt and disciplined financial "treatment" will improve the prognosis and enable sustainable growth.

---